Sofinnova Digital Medicine Fund I

About Sofinnova Digital Medicine Fund I

Early-stage digital health: biology, data, computation, enabling tech, analytics, treatment. Seed, Series A. Portfolio: Kiro, BioCorteX, deepc, L'école AI, Betteromics.

Investment Focus

Location / RegionFrance

Funding StageSeed

Industry Focus

Ai Ml

Biotech

Digital Health

Investor Signals Profile

active

Sweet Spot

Clinical-stage biotech founders with human trial data

biotech

life sciences

clinical-stage

therapeutics

reproductive health

Bullish Signals

Portfolio co hits positive Phase 1 dataexternal

Freya FB301: positive first-in-human IVF datawebsite

FB301 targets embryo implantation failurewebsite

Freya FB301 Phase 1 officially announcedwebsite

Contrarian Signals

No contrarian signals recorded.

Founder Do's

Show clinical data early

Highlight IVF/reproductive health angle

Lead with first-in-human milestones

Founder Don'ts

No red flags recorded.

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€190M

Saves0

Website

Key People

Edward Kliphuis, Simon Turner, Antoine Papiernik